Tuesday, 7th of June 2016 |
J Infect Dis. (2016) doi: 10.1093/infdis/jiv580 First published online: February 24, 2016
The most recent version of this article [jiv580] was published on 2016-04-02
Strengthening Routine Immunization in Areas of Northern Nigeria at High Risk for Polio Transmission During 2012–2014
+ Author Affiliations
1World Health Organization, Country Representative Office
2National Primary Health Care Development Agency, Abuja, Nigeria
3World Health Organization, Regional Office for Africa, Brazzaville, Congo
Correspondence: D. Ali, Health Organization, Nigeria Country Office, Abuja, Nigeria (alid@who.int).
Abstract below; full text is at http://jid.oxfordjournals.org/content/early/2016/02/24/infdis.jiv580.full
Background. Following the 2012 declaration by World Health Organization (WHO) Regional Director for Africa and the WHO Executive Board to ramp up routine immunization (RI) activities, began to intensify activities to strengthen RI. This study assessed how the intensification of RI helped strengthen service delivery in local government areas (LGAs) of northern Nigeria at high risk for polio transmission.
Methods. A retrospective study was performed by analyzing RI administrative data and findings from supportive supervisory visits in 107 high-risk LGAs.
Results. Our study revealed that administrative coverage with 3rd dose of diphtheria-pertussis-tetanus vaccine in the 107 high-risk LGAs improved from a maximum average coverage of 33% during the preintensification period of 2009–2011 to 74% during the postintensification period of 2012–2014.
Conclusions. Routine immunization could be strengthened in areas where coverage is low, and RI has been identified to be weak when certain key routine activities are intensified.
Key words
routine immunization, intensification
polio, high risk, local government areas
© 2016 World Health Organization; licensee Oxford Journals.
This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (http://creativecommons.org/licenses/by/3.0/igo/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organisation or products. The use of the WHO logo is not permitted. This notice should be preserved along with the articles original URL.
CORRECTED PROOF
This Article
J Infect Dis. (2016) doi: 10.1093/infdis/jiv580 First published online: February 24, 2016
This article is Open AccessOA
Are three drugs for malaria better than two?
Friday, 24th of April 2020 |
Public health Interventions and epidemic intensity during the 1918 influenza pandemic
Thursday, 16th of April 2020 |
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Tuesday, 17th of March 2020 |
Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications
Monday, 17th of February 2020 |
Immunization Agenda 2030
Tuesday, 11th of February 2020 |
41152846 |
www.measlesinitiative.org www.technet21.org www.polioeradication.org www.globalhealthlearning.org www.who.int/bulletin allianceformalariaprevention.com www.malariaworld.org http://www.panafrican-med-journal.com/ |